Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Mannose-P-Dolichol Utilization Defect 1 Produkte

(Mannose-P-Dolichol Utilization Defect 1 (MPDU1))

Kategorien

This gene encodes an endoplasmic reticulum membrane protein that is required for utilization of the mannose donor mannose-P-dolichol in the synthesis of lipid-linked oligosaccharides and glycosylphosphatidylinositols. Mutations in this gene result in congenital disorder of glycosylation type If. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2008].

antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.

Ausgewählte Mannose-P-Dolichol Utilization Defect 1 Kategorien

Mannose-P-Dolichol Utilization Defect 1 Antikörper

High quality antibodies with extensive validation data.

Empfohlene Mannose-P-Dolichol Utilization Defect 1 Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Applikation ELISA, IHC, IF
Validierungen
  • (2)
Kat. Nr. ABIN7158987
Menge 100 μg
Datenblatt Datenblatt
Reaktivität Human
Applikation WB
Validierungen
  • (4)
  • (1)
Kat. Nr. ABIN1881550
Menge 400 μL
Datenblatt Datenblatt
Reaktivität Human
Applikation ELISA
Validierungen
Kat. Nr. ABIN7158990
Menge 100 μg
Datenblatt Datenblatt

Neueste Publikationen zu unseren Mannose-P-Dolichol Utilization Defect 1 Produkten

Guey, García-Closas, Murta-Nascimento, Lloreta, Palencia, Kogevinas, Rothman, Vellalta, Calle, Marenne, Tardón, Carrato, García-Closas, Serra, Silverman, Chanock, Real, Malats: "Genetic susceptibility to distinct bladder cancer subphenotypes." in: European urology, Vol. 57, Issue 2, pp. 283-92, (2010) (PubMed).

Hosgood, Menashe, He, Chanock, Lan: "PTEN identified as important risk factor of chronic obstructive pulmonary disease." in: Respiratory medicine, Vol. 103, Issue 12, pp. 1866-70, (2009) (PubMed).

Shen, Vermeulen, Rajaraman, Menashe, He, Chapman, Yeager, Thomas, Burdett, Hutchinson, Yuenger, Chanock, Lan: "Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China." in: Environmental and molecular mutagenesis, Vol. 50, Issue 4, pp. 285-90, (2009) (PubMed).

Hosgood, Menashe, Shen, Yeager, Yuenger, Rajaraman, He, Chatterjee, Caporaso, Zhu, Chanock, Zheng, Lan: "Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway." in: Carcinogenesis, Vol. 29, Issue 10, pp. 1938-43, (2008) (PubMed).

Synonyme und alternative Namen zu Mannose-P-Dolichol Utilization Defect 1

mannose-P-dolichol utilization defect 1 (MPDU1), mannose-P-dolichol utilization defect 1 (Mpdu1), mannose-P-dolichol utilization defect 1a (mpdu1a), cystinosin/ERS1p repeat-containing protein (mpdu1), mannose-P-dolichol utilization defect 1 (LOC692905), mannose-P-dolichol utilization defect 1b (mpdu1b), CDGIF, DDBDRAFT_0237930, DDB_0237930, fb18d03, HBEBP2BPA, Lec35, LEC35, mpdu1, MPDU1, My008, PP3958, PQLC5, SL15, Supl15h, wu:fb18d03, zgc:86765, zgc:92112

Bezeichner auf Proteinebene für Mannose-P-Dolichol Utilization Defect 1

  • HBeAg-binding protein 2 binding protein A
  • mannose-P-dolichol utilization defect 1 protein
  • suppressor of Lec15 and Lec35 glycosylation mutation homolog
  • suppressor of Lec15 homolog (C.griseus)
  • mannose-P-dolichol utilization defect 1
  • transmembrane protein
  • suppressor of Lec15 glycosylation mutation-like protein
Sie sind hier:
Kundenservice